Saturday | 30 August, 2008
Australian Biotechnology News

Stories about: Laser

  • +

    Shining a light on membrane proteins 24/06/2008 11:36:26

    Put together a mixture of biologists, biochemists and physicists and you might get a lot of blank faces, particularly when hard-core physics is being discussed. However physics and biology have come together to solve one of science's big issues - the structure of membrane proteins - through the ARC Centre of Excellence for Coherent X-ray Science.
  • +

    Geneticists to the internet's rescue 06/02/2008 12:49:39

    Genetic analysis of light fingers noise problem
  • +

    Proteomics for cancer diagnostics 18/12/2007 11:00:13

    Genomics is old hat and proteomics is now where it's at, according to Richard Christopherson.
  • +

    Seeing the light in femtoseconds 28/11/2007 12:20:51

    Speedy laser facility will be used for biological imaging.
  • +

    MicroRNAs: thinking globally, acting locally 28/11/2007 11:10:49

    Neurologist Ken Kosik and his team are profiling neuronal miRNAs to identify those potentially involved in neuronal plasticity and the function of those that are unique to dendrites.
  • +

    Multiphoton beast is unleashed 21/11/2007 11:28:36

    A $900,000 multiphoton microscope at Sydney's Centenary Institute has been unveiled.
  • +

    FABLS up in lights 02/11/2007 16:34:40

    The Australian Research Network for Fluorescence Applications in Biotechnology and Life Sciences (FABLS) has access to a staggering array of Australian and overseas instrumentation and expertise in fluorescence technology and applications.
  • +

    From baker to brewer 02/11/2007 16:33:06

    Rob Learmonth is using his fluorescence expertise to help the most needy - Australia's beer and wine drinkers.
  • +

    BIO profile: The hope beyond the hype 17/04/2007 10:22:32

    The CSIRO is sponsoring a session on biomaterials and regenerative medicine at BIO2007. Kate McDonald spoke to CSIRO's theme leader for the area, Keith McLean, about this competitive but challenging field.
  • +

    Tackling skin cancer in organ transplant patients 13/04/2007 11:37:48

    Clinuvel Pharmaceuticals is heading into further Phase II and beginning Phase III trials for several UV-related indications for its photo-protective drug CUV1647. The big hope, however, is its potential to protect organ transplant recipients.
  • +

    New oncology application for Clinuvel 23/03/2007 16:16:18

    Clinuvel has identified a new application for its photoprotective drug, this time in cancer patients.
Additional Resources

Newsletter Subscription

Sign up for our Australian Life Scientist newsletters!
The latest, most important headlines from Australia and around the world.
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world.

Australian Life Scientist Member Login

 
Sponsored Links